Biomarker profile and genetic abnormalities in lobular carcinoma in situ
Authors:
- 1 April 2005
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 90 (3) , 249-256
Abstract
The predisposition of patients with lobular carcinoma in situ (LCIS) to develop invasive breast cancer (IBC) is well known. However, relatively little is known about the biologic characteristics, which may be involved in the development and progression of LCIS. This study evaluated 59 cases of LCIS (29 pure, 30 with synchronous IBC) for five biomarkers known to be important in IBC (ER, PgR, c-erbB-2, p53 and Ki-67 proliferation rate) by immunohistochemistry. A comprehensive analysis of loss-of-heterozygosity (LOH) was performed in 12 cases (10 pure, 2 with synchronous IBC) at 15 genetic loci on 9 chromosomes. LCIS demonstrated a low grade/favorable biophenotype that was not significantly different in cases with and without synchronous IBC (ER 98%, PgR 84%, c-erbB-24%, p53 19% and proliferation rate 2%). LOH was present in 80% of pure LCIS and the highest rates of LOH were at loci on 9p (30%), 16q (63%), 17p (33%) and 17q (50%). The clustering of LOH at these four foci suggests that inactivated tumor suppressor genes in these regions may be particularly important. LOH was present in both cases of LCIS with synchronous IBC and the LOH phenotype was shared by LCIS and IBC. Our findings suggest that five known prognostic factors in IBC do not have prognostic utility in LCIS. Multiple genetic mechanisms may be involved in the development of LCIS.Keywords
This publication has 45 references indexed in Scilit:
- Mammographically detected in situ lobular carcinomas of the breastVirchows Archiv, 2000
- E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesisBritish Journal of Cancer, 1997
- Loss of heterozygosity on chromosome 11 q 13 in lobular lesions of the breast using tissue microdissection and polymerase chain reactionHuman Pathology, 1997
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 1993
- Atypical hyperplastic lesions of the female breast. A long-term follow-up studyCancer, 1985
- Infiltrating lobular carcinoma of the breastHistopathology, 1982
- Intraductal carcinoma of the breast: Follow-up after biopsy onlyCancer, 1982
- Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 yearsAmerican Journal of Surgical Pathology, 1978
- Lobular neoplasia (so-called lobular carcinoma in situ) of the breastCancer, 1978
- Lobular carcinoma in situ of the breast(Long-term followupCancer, 1974